| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DEXCOM INC | 56,900 | 4,821,000 | 0.76% | ||
| 52 | PORTOLA PHARMACEUTICALS INC | 120,805 | 4,734,000 | 0.75% | ||
| 53 | ENDO INTL PLC | 402,303 | 4,490,000 | 0.71% | ||
| 54 | REVANCE THERAPEUTICS INC COM | 210,000 | 4,368,000 | 0.69% | ||
| 55 | UNIVERSAL HLTH SVCS INC | 35,000 | 4,356,000 | 0.69% | ||
| 56 | RIGEL PHARMACEUTICAL INC | 1,282,000 | 4,243,000 | 0.67% | ||
| 57 | NXSTAGE MED INC COM | 153,901 | 4,129,000 | 0.65% | ||
| 58 | OMNICELL INC | 98,537 | 4,006,000 | 0.63% | ||
| 59 | AERIE PHARMACEUTICALS INC COM | 85,000 | 3,855,000 | 0.61% | ||
| 60 | FIBROGEN INC | 154,341 | 3,805,000 | 0.60% | ||
| 61 | DAVITA INC | 55,000 | 3,738,000 | 0.59% | ||
| 62 | WALGREENS BOOTS ALLIANCE INC | 45,000 | 3,737,000 | 0.59% | ||
| 63 | NEUROCRINE BIOSCIE COM USD0.001 | 85,000 | 3,681,000 | 0.58% | ||
| 64 | MYLAN N V | 90,000 | 3,509,000 | 0.56% | ||
| 65 | INTERCEPT PHARMACEUTICALS INCORPORATED | 30,000 | 3,393,000 | 0.54% | ||
| 66 | MACROGENICS INC | 175,000 | 3,255,000 | 0.52% | ||
| 67 | ARRAY BIOPHARMA INC | 350,000 | 3,129,000 | 0.50% | ||
| 68 | IMMUNOMEDICS INCORPORATED | 479,610 | 3,103,000 | 0.49% | ||
| 69 | ACADIA PHARMACEUTICALS INC COM | 90,000 | 3,094,000 | 0.49% | ||
| 70 | LABORATORY CORP AMER HLDGS | 21,550 | 3,092,000 | 0.49% | ||
| 71 | INTUITIVE SURGICAL INC | 4,000 | 3,066,000 | 0.49% | ||
| 72 | RADIUS HEALTH INCORPORATED COM NEW | 75,000 | 2,899,000 | 0.46% | ||
| 73 | TETRAPHASE PHARMACEUTICALS INC COM | 300,000 | 2,757,000 | 0.44% | ||
| 74 | ADAMAS PHARMACEUTICALS INC | 155,000 | 2,713,000 | 0.43% | ||
| 75 | KERYX BIOPHARMACEUTICALS INCORPORATED | 425,111 | 2,619,000 | 0.41% | ||
| 76 | CHIMERIX INC | 400,000 | 2,552,000 | 0.40% | ||
| 77 | COHERUS BIOSCIENCES INC COM | 111,357 | 2,355,000 | 0.37% | ||
| 78 | HALOZYME THERAPEUTICS INC | 170,000 | 2,203,000 | 0.35% | ||
| 79 | BIOVERATIV INC | 31,000 | 1,688,000 | 0.27% | ||
| 80 | INSULET CORPORATION | 35,000 | 1,508,000 | 0.24% | ||
| 81 | REGULUS THERAPEUTICS INC COM | 593,629 | 979,000 | 0.16% | ||
| 82 | BECTON DICKINSON & CO | 5,000 | 917,000 | 0.15% | ||
| 83 | TESARO INCORPORATED | 5,000 | 769,000 | 0.12% | ||
| 84 | ACHILLION PHARMACEUTICALS IN | 166,000 | 699,000 | 0.11% | ||
| 85 | CONCERT PHARMACEUTICALS INCORPORATED | 30,099 | 513,000 | 0.08% | ||
| 86 | Catabasis Pharmaceuticals Inc | 310,756 | 497,000 | 0.08% | ||
| 87 | JPMORGAN CHASE & CO | 4,837 | 425,000 | 0.07% | ||
| 88 | ADVERUM BIOTECHNOLOGIES INC | 154,006 | 416,000 | 0.07% | ||
| 89 | OREXIGEN THERAPEUTICS INC | 120,000 | 413,000 | 0.07% | ||
| 90 | WELLS FARGO & CO NEW | 7,305 | 407,000 | 0.06% | ||
| 91 | EXXON MOBIL CORP | 4,823 | 396,000 | 0.06% | ||
| 92 | HALLIBURTON CO | 7,718 | 380,000 | 0.06% | ||
| 93 | OCULAR THERAPEUTIX INC | 40,000 | 371,000 | 0.06% | ||
| 94 | MICROSOFT CORP | 4,793 | 316,000 | 0.05% | ||
| 95 | INTERNATIONAL BUSINESS MACHS | 1,766 | 308,000 | 0.05% | ||
| 96 | ANHEUSER BUSCH INBEV SA/NV | 2,806 | 308,000 | 0.05% | ||
| 97 | QUALCOMM INC | 5,368 | 308,000 | 0.05% | ||
| 98 | STAAR Surgical Co | 28,711 | 281,000 | 0.04% | ||
| 99 | TANDEM DIABETES CARE INC COM | 234,000 | 281,000 | 0.04% | ||
| 100 | FORD MTR CO DEL | 22,511 | 262,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-17-000651, filed 2017.04.19).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
